The FDA recently changed the label for the drug meropenem to reflect findings from a study conducted by PTN investigators. Results from the study were published in the Pediatric Infectious Disease Journal.
The FDA recently changed the label for the drug meropenem to reflect findings from a study conducted by PTN investigators. Results from the study were published in the Pediatric Infectious Disease Journal.